CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Cilazapril

西拉普利 杂质对照品Cilazapril Impurities

EP60 个杂质条目60 impurity entries

本页汇总 西拉普利 的 60 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 60 impurity reference standards of Cilazapril with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 西拉普利(Cilazapril)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesRapid and simple stability indicating HPLC method for the determination of cilazapril in pure substance and pharmaceutical formulation in comparison with classic and derivative spectrophotometric methods
    Acta poloniae pharmaceutica · 2012 · Paszun SK et al.  ·  PMID 22568033
  2. 杂质研究Impurity studiesUse of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril
    Journal of pharmaceutical and biomedical analysis · 2015 · Narayanam M et al.  ·  PMID 25890215  ·  DOI
  3. 杂质研究Impurity studiesMulticriteria Optimization Methodology in Stability-Indicating Method Development of Cilazapril and Hydrochlorothiazide
    Journal of chromatographic science · 2017 · Šljivic J et al.  ·  PMID 28334985  ·  DOI
  4. 分析方法Analytical MethodsAdvantages of automation in plasma sample preparation prior to HPLC/MS/MS quantification: application to the determination of cilazapril and cilazaprilat in a bioequivalence study
    Journal of AOAC International · 2011 · Kolocouri F et al.  ·  PMID 21797003
  5. 分析方法Analytical MethodsStability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms
    Acta poloniae pharmaceutica · 2014 · Stanisz BJ et al.  ·  PMID 25272892

西拉普利 —— 原料药与杂质对照品Cilazapril — drug substance & impurities

共 60 个条目(含原料药本体)60 items incl. the drug substance
Cilazapril Impurity 1 (Cilazapril EP Impurity A) structure
EPA
西拉普利杂质1 (西拉普利EP杂质 A)Cilazapril Impurity 1 (Cilazapril EP Impurity A)
Cilazapril Impurity 1 (Cilazapril EP Impurity A)
CAS No.106860-19-9
Chemical FormulaC26H39N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cilazapril Impurity 2 (Cilazapril EP Impurity B) structure
EPB
西拉普利杂质2 (西拉普利EP杂质 B)Cilazapril Impurity 2 (Cilazapril EP Impurity B)
Cilazapril Impurity 2 (Cilazapril EP Impurity B)
CAS No.90139-06-3
Chemical FormulaC20H27N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cilazapril Impurity 4 (Cilazapril EP Impurity D) structure
EPD
西拉普利杂质4 (西拉普利EP杂质 D)Cilazapril Impurity 4 (Cilazapril EP Impurity D)
Cilazapril Impurity 4 (Cilazapril EP Impurity D)
CAS No.106928-09-0
Chemical FormulaC22H31N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cilazapril Impurity 5 (N-Nitroso Cilazapril) structure
5
西拉普利杂质5 (N-亚硝基西拉普利)Cilazapril Impurity 5 (N-Nitroso Cilazapril)
Cilazapril Impurity 5 (N-Nitroso Cilazapril)
CAS No.1053740-92-3
Chemical FormulaC22H30N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Cilazapril Impurity 7 structure
7
西拉普利杂质7Cilazapril Impurity 7
Cilazapril Impurity 7
CAS No.106928-07-8
Chemical FormulaC22H31N3O5
Purity>95%询价On request
10mg25mg50mg100mg
8
西拉普利杂质8Cilazapril Impurity 8
Cilazapril Impurity 8
CAS No.104013-57-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
9
西拉普利杂质9Cilazapril Impurity 9
Cilazapril Impurity 9
CAS No.106928-08-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
10
西拉普利杂质10Cilazapril Impurity 10
Cilazapril Impurity 10
CAS No.88824-65-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
11
西拉普利杂质11Cilazapril Impurity 11
Cilazapril Impurity 11
CAS No.104013-55-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
12
西拉普利杂质12Cilazapril Impurity 12
Cilazapril Impurity 12
CAS No.106928-06-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
13
西拉普利杂质13Cilazapril Impurity 13
Cilazapril Impurity 13
CAS No.88851-56-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
14
西拉普利杂质14Cilazapril Impurity 14
Cilazapril Impurity 14
CAS No.1905397-51-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
15
西拉普利杂质15Cilazapril Impurity 15
Cilazapril Impurity 15
CAS No.90193-33-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
18
西拉普利杂质18Cilazapril Impurity 18
Cilazapril Impurity 18
CAS No.811787-70-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
19
西拉普利杂质19Cilazapril Impurity 19
Cilazapril Impurity 19
CAS No.216975-49-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
20
西拉普利杂质20Cilazapril Impurity 20
Cilazapril Impurity 20
CAS No.811787-72-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
21
西拉普利杂质21Cilazapril Impurity 21
Cilazapril Impurity 21
CAS No.811787-71-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
22
西拉普利杂质22Cilazapril Impurity 22
Cilazapril Impurity 22
CAS No.764603-92-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
23
西拉普利杂质23Cilazapril Impurity 23
Cilazapril Impurity 23
CAS No.752158-50-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
24
西拉普利杂质24Cilazapril Impurity 24
Cilazapril Impurity 24
CAS No.752158-48-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
25
西拉普利杂质25Cilazapril Impurity 25
Cilazapril Impurity 25
CAS No.756500-47-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
26
西拉普利杂质26Cilazapril Impurity 26
Cilazapril Impurity 26
CAS No.749804-91-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
27
西拉普利杂质27Cilazapril Impurity 27
Cilazapril Impurity 27
CAS No.1416728-88-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
28
西拉普利杂质28Cilazapril Impurity 28
Cilazapril Impurity 28
CAS No.88768-32-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
29
西拉普利杂质29Cilazapril Impurity 29
Cilazapril Impurity 29
CAS No.88768-18-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
30
西拉普利杂质30Cilazapril Impurity 30
Cilazapril Impurity 30
CAS No.1416728-94-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
31
西拉普利杂质31Cilazapril Impurity 31
Cilazapril Impurity 31
CAS No.811787-73-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
32
西拉普利杂质32Cilazapril Impurity 32
Cilazapril Impurity 32
CAS No.117016-98-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
33
西拉普利杂质33Cilazapril Impurity 33
Cilazapril Impurity 33
CAS No.1416728-74-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
34
西拉普利杂质34Cilazapril Impurity 34
Cilazapril Impurity 34
CAS No.752939-91-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
35
西拉普利杂质35Cilazapril Impurity 35
Cilazapril Impurity 35
CAS No.811787-66-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
36
西拉普利杂质36Cilazapril Impurity 36
Cilazapril Impurity 36
CAS No.811787-64-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
37
西拉普利杂质37Cilazapril Impurity 37
Cilazapril Impurity 37
CAS No.811787-63-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
38
西拉普利杂质38Cilazapril Impurity 38
Cilazapril Impurity 38
CAS No.1416728-90-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
39
西拉普利杂质39Cilazapril Impurity 39
Cilazapril Impurity 39
CAS No.1416728-83-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
40
西拉普利杂质40Cilazapril Impurity 40
Cilazapril Impurity 40
CAS No.88824-62-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
41
西拉普利杂质41Cilazapril Impurity 41
Cilazapril Impurity 41
CAS No.88767-97-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
42
西拉普利杂质42Cilazapril Impurity 42
Cilazapril Impurity 42
CAS No.1416728-92-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
43
西拉普利杂质43Cilazapril Impurity 43
Cilazapril Impurity 43
CAS No.811787-68-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
44
西拉普利杂质44Cilazapril Impurity 44
Cilazapril Impurity 44
CAS No.88851-64-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
45
西拉普利杂质45Cilazapril Impurity 45
Cilazapril Impurity 45
CAS No.88768-20-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
46
西拉普利杂质46Cilazapril Impurity 46
Cilazapril Impurity 46
CAS No.117017-26-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
47
西拉普利杂质47Cilazapril Impurity 47
Cilazapril Impurity 47
CAS No.117066-19-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
48
西拉普利杂质48Cilazapril Impurity 48
Cilazapril Impurity 48
CAS No.117017-15-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
49
西拉普利杂质49Cilazapril Impurity 49
Cilazapril Impurity 49
CAS No.88768-01-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
50
西拉普利杂质50Cilazapril Impurity 50
Cilazapril Impurity 50
CAS No.764610-88-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
51
西拉普利杂质51Cilazapril Impurity 51
Cilazapril Impurity 51
CAS No.1416728-93-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
52
西拉普利杂质52Cilazapril Impurity 52
Cilazapril Impurity 52
CAS No.88824-72-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
53
西拉普利杂质53Cilazapril Impurity 53
Cilazapril Impurity 53
CAS No.88768-17-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
54
西拉普利杂质54Cilazapril Impurity 54
Cilazapril Impurity 54
CAS No.1416728-95-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
55
西拉普利杂质55Cilazapril Impurity 55
Cilazapril Impurity 55
CAS No.117067-13-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
56
西拉普利杂质56Cilazapril Impurity 56
Cilazapril Impurity 56
CAS No.117017-03-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
57
西拉普利杂质57Cilazapril Impurity 57
Cilazapril Impurity 57
CAS No.88824-73-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
58
西拉普利杂质58Cilazapril Impurity 58
Cilazapril Impurity 58
CAS No.88768-23-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
59
西拉普利杂质59Cilazapril Impurity 59
Cilazapril Impurity 59
CAS No.117017-01-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
60
西拉普利杂质60Cilazapril Impurity 60
Cilazapril Impurity 60
CAS No.106860-25-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
61
西拉普利杂质61Cilazapril Impurity 61
Cilazapril Impurity 61
CAS No.1346836-04-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
62
西拉普利杂质62Cilazapril Impurity 62
Cilazapril Impurity 62
CAS No.88768-04-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
63
西拉普利杂质63Cilazapril Impurity 63
Cilazapril Impurity 63
CAS No.106880-16-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
64
西拉普利杂质64Cilazapril Impurity 64
Cilazapril Impurity 64
CAS No.786597-66-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

西拉普利 —— 研究文献与合成路线Cilazapril — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 西拉普利 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Cilazapril. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Rapid and simple stability indicating HPLC method for the determination of cilazapril in pure substance and pharmaceutical formulation in comparison with classic and derivative spectrophotometric methods
    Paszun SK, Stanisz B, Pawłowski W · Acta poloniae pharmaceutica · 2012 · 被引 2cited 2
  2. Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril
    Narayanam M, Sahu A, Singh S · Journal of pharmaceutical and biomedical analysis · 2015 · 被引 11cited 11
  3. Determination of active ingredients in the pharmaceutical formulations containing hydrochlorothiazide and its binary mixtures with benazepril hydrochloride, triamterene and cilazapril by ratio spectra derivative spectrophotometry and vierordt's method
    Erk N · Journal of pharmaceutical and biomedical analysis · 1999 · 被引 35cited 35
  4. Voltammetric determination of cilazapril in pharmaceutical formulations
    Tamer U, Pekmez Ozçiçek N, Atay O, et al. · Journal of pharmaceutical and biomedical analysis · 2002 · 被引 4cited 4
  5. Square wave voltammetric determination of the angiotensin-converting enzyme inhibitors cilazapril, quinapril and ramipril in pharmaceutical formulations
    Prieto JA, Jiménez RM, Alonso RM · Farmaco (Societa chimica italiana : 1989) · 2003 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION OF AN INTERMEDIATE OF CILAZAPRIL
    KUMAR HARISH, ARORA SANJEEV KUMAR, SINGH KAPTAN, PRASAD MOHAN, et al. · 公开号 WO2012049646WO2012049646 · 2012
  2. Preparation of cilazapril intermediates
    ELIAS SERGIO ARTURO FERRINO, KUNHIMON SYAM KUMAR UNNIARANPURAKKAL, MORE SATISH SUKHLAL, TOVAR EDUARDO, et al. · 公开号 EP2221299EP2221299 · 2010
  3. Enantiomerically pure cilazapril, process for preparation
    KUMAR YATENDRA, PRASAD MOHAN, SINGH KAPTAN, RAMANA KINTALI V, et al. · 公开号 US2006293517US2006293517 · 2006
  4. Antihypertensive drug cilazapril intermediate and preparation method thereof
    CHAO TANG, JINGFEN ZHONG, HUILIN SHI · 公开号 CN101560204CN101560204 · 2009
  5. A NOVEL PROCESS FOR THE PREPARATION OF CILAZAPRIL
    PARTHASARADHI REDDY BANDI, RATHNAKAR REDDY KURA, RAJI REDDY RAPOLU, MURALIDHARA REDDY DASARI · 公开号 WO2005003134WO2005003134 · 2005

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

西拉普利 杂质谱研究要点Cilazapril — impurity profiling notes

下面这些是拿到 西拉普利 的 60 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 60 impurity entries for Cilazapril, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances